LOMBARD MEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -.--% |
| Sales 2015 | 15.11M 18.94M 25.88M | Sales 2016 | 12.17M 15.25M 20.84M | Capitalization | 16.77M 21.01M 28.71M |
|---|---|---|---|---|---|
| Net income 2015 | -37M -46.37M -63.35M | Net income 2016 | -31M -38.85M -53.08M | EV / Sales 2015 | 1.17 x |
| Net cash position 2015 | 9.22M 11.55M 15.78M | Net Debt 2016 | 13.76M 17.25M 23.56M | EV / Sales 2016 | 2.51 x |
| P/E ratio 2015 |
-0.63
x | P/E ratio 2016 |
-0.39
x | Employees | 113 |
| Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
3 years
0.00
0.05
5 years
0.000.10
10 years
0.0010.01
Lombard Medical, Inc. is a medical device company. The Company is focused solely on the minimally invasive treatment of aortic disease. The Company partners with MicroPort Endovastec to offer Minos abdominal aortic aneurysm (AAA) stent-graft, the Hercules TAA stent graft and the Castor Branched Thoracic stent graft, in addition to its own Aorfix and Altura stent grafts. The Companyâs products include Minos, Aorfix, Altura, Meridian, Hercules, Castor, and Hercules Balloon.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 27 | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +1.63% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- EVARF Stock
